Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin for Bowel Dysfunction After Rectal Surgery
NCT01345175Phase 3Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Apr 2011
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bowel dysfunction comparing Rifaximin Arm with Placebo Arm (2 arms). Primary endpoint: Number of Participants Who Completed MSKCC Bowel Function Instrument (BFI Score) at 1 year. Started Apr 2011; status: completed.
02
Drugs
rifaximin
03
Conditions
bowel dysfunction
Beyond the preview
Go deeper on NCT01345175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01345175.